- Home
- WMB vs ZTS Comparison
WMB vs ZTS Comparison
Compare WMB & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMB
- ZTS
- Stock Information
- Founded
- WMB 1908
- ZTS 1952
- Country
- WMB United States
- ZTS United States
- Employees
- WMB N/A
- ZTS N/A
- Industry
- WMB Natural Gas Distribution
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- WMB Utilities
- ZTS Health Care
- Exchange
- WMB Nasdaq
- ZTS Nasdaq
- Market Cap
- WMB 69.7B
- ZTS 66.2B
- IPO Year
- WMB N/A
- ZTS 2013
- Fundamental
- Price
- WMB $58.41
- ZTS $146.31
- Analyst Decision
- WMB Buy
- ZTS Buy
- Analyst Count
- WMB 16
- ZTS 8
- Target Price
- WMB $60.67
- ZTS $200.25
- AVG Volume (30 Days)
- WMB 5.6M
- ZTS 2.4M
- Earning Date
- WMB 11-05-2025
- ZTS 11-03-2025
- Dividend Yield
- WMB 3.42%
- ZTS 1.37%
- EPS Growth
- WMB N/A
- ZTS 14.10
- EPS
- WMB 1.99
- ZTS 5.82
- Revenue
- WMB $11,363,000,000.00
- ZTS $9,385,000,000.00
- Revenue This Year
- WMB $10.55
- ZTS $3.90
- Revenue Next Year
- WMB $7.15
- ZTS $6.00
- P/E Ratio
- WMB $29.38
- ZTS $25.17
- Revenue Growth
- WMB 10.83
- ZTS 5.27
- 52 Week Low
- WMB $44.51
- ZTS $139.70
- 52 Week High
- WMB $63.45
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- WMB 53.30
- ZTS 35.12
- Support Level
- WMB $56.09
- ZTS $148.38
- Resistance Level
- WMB $59.35
- ZTS $152.00
- Average True Range (ATR)
- WMB 1.05
- ZTS 2.81
- MACD
- WMB 0.21
- ZTS -0.81
- Stochastic Oscillator
- WMB 71.17
- ZTS 3.92
About WMB Williams Companies Inc. (The)
Williams Companies is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.